Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00051194 | A 6-week Safety & Efficacy Study of Combination Intraocular Pressure-lowering Therapy in Patients With Open-angle Glaucoma or Ocular Hypertension | PHASE2 | COMPLETED | - | — | — | Sep 1, 2002 | Jul 1, 2003 | Apr 16, 2012 | 1 | United States |
| Name | Type | Description |
|---|---|---|
| Combination IOP Lowering Therapy | DRUG | - |
Adult patients of any race and either sex with open angle glaucoma or ocular hypertension.